Advertisement
U.S. markets open in 1 hour 56 minutes

Rigel Pharmaceuticals, Inc. (RIGL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
1.3400-0.0200 (-1.47%)
At close: 04:00PM EDT
1.3300 -0.01 (-0.75%)
Pre-Market: 05:56AM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 3/19/2024
Current
12/31/20239/30/20236/30/20233/31/202312/31/2022
Market Cap (intraday)
235.01M252.84M188.31M224.92M229.24M259.25M
Enterprise Value
238.65M251.28M184.62M227.00M212.59M220.39M
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
2.001.901.481.721.892.89
Price/Book (mrq)
N/AN/AN/AN/AN/AN/A
Enterprise Value/Revenue
2.047.026.568.448.154.30
Enterprise Value/EBITDA
-14.0585.56-52.73-51.10-17.7578.94

Trading Information

Stock Price History

Beta (5Y Monthly) 0.96
52-Week Change 3-4.29%
S&P500 52-Week Change 328.64%
52 Week High 31.9600
52 Week Low 30.7100
50-Day Moving Average 31.3264
200-Day Moving Average 31.2153

Share Statistics

Avg Vol (3 month) 31.11M
Avg Vol (10 day) 31.79M
Shares Outstanding 5175.38M
Implied Shares Outstanding 6189.77M
Float 8146.97M
% Held by Insiders 12.06%
% Held by Institutions 161.57%
Shares Short (Feb 29, 2024) 43.74M
Short Ratio (Feb 29, 2024) 43.64
Short % of Float (Feb 29, 2024) 42.16%
Short % of Shares Outstanding (Feb 29, 2024) 42.13%
Shares Short (prior month Jan 31, 2024) 43.42M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:9
Last Split Date 3Jun 25, 2003

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -21.67%
Operating Margin (ttm)5.23%

Management Effectiveness

Return on Assets (ttm)-10.73%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)115.78M
Revenue Per Share (ttm)0.67
Quarterly Revenue Growth (yoy)-27.60%
Gross Profit (ttm)N/A
EBITDA -20.35M
Net Income Avi to Common (ttm)-25.09M
Diluted EPS (ttm)-0.1400
Quarterly Earnings Growth (yoy)-47.40%

Balance Sheet

Total Cash (mrq)56.93M
Total Cash Per Share (mrq)0.32
Total Debt (mrq)104.17M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.86
Book Value Per Share (mrq)-0.16

Cash Flow Statement

Operating Cash Flow (ttm)-5.74M
Levered Free Cash Flow (ttm)-25.82M